Recombinant Ostreid herpesvirus 1 Uncharacterized protein ORF84 (ORF84)

What is Ostreid herpesvirus 1 (OsHV-1) and why is ORF84 important?

Ostreid herpesvirus 1 (OsHV-1) is a double-stranded DNA virus belonging to the family Malacoherpesviridae, order Herpesvirales. It is the causative agent of Pacific oyster mortality syndrome (POMS), which has significantly impacted oyster aquaculture worldwide, particularly affecting Crassostrea gigas (Pacific oyster) .

ORF84 encodes a capsid-associated protein that plays a structural role in the virus. This protein is particularly important because:

• It is one of the most expressed viral genes during infection

• It can be detected early in infection (from 4 hours post-infection)

• It shows a distinctive expression pattern with an 8-10 fold increase during the first 5 days post-infection

• As a structural component, it represents a potential target for diagnostic tests and antiviral interventions

Understanding ORF84 provides insights into viral assembly, structure, and potential vulnerabilities that could be exploited for disease management strategies.

What methods are used to express recombinant OsHV-1 ORF84 protein?

Several methodological approaches have been developed to express recombinant OsHV-1 ORF84 protein:

Prokaryotic Expression Systems:

• E. coli expression: The ORF84 coding sequence can be amplified using PCR and cloned into bacterial expression vectors (such as pET series vectors) with an N-terminal His-tag for purification .

• Codon optimization: Since viral codon usage may differ from bacterial systems, codon optimization is often necessary to improve expression efficiency.

• Inclusion body solubilization: ORF84 may form inclusion bodies requiring solubilization using 8M urea followed by refolding protocols.

Eukaryotic Expression Systems:

• Baculovirus expression: For better folding and post-translational modifications, the ORF84 coding sequence can be cloned into baculovirus transfer vectors and expressed in insect cells.

• Mammalian cell expression: For functional studies, ORF84 can be cloned into mammalian expression vectors and transfected into cell lines such as HEK293T.

Purification Approaches:

• Affinity chromatography using Ni-NTA columns for His-tagged proteins

• Size exclusion chromatography for further purification

• Ion exchange chromatography to remove contaminants

The choice of expression system depends on downstream applications such as structural studies, antibody production, or functional characterization.

How can researchers confirm the authenticity of recombinant ORF84 expression?

Verification of recombinant ORF84 expression and authenticity requires multiple complementary approaches:

Molecular Confirmation:

• Western blotting: Using either anti-His tag antibodies (if tagged) or specific antibodies against ORF84

• Mass spectrometry: For peptide mass fingerprinting and sequence verification

• N-terminal sequencing: To confirm the correct translation start site

Functional Validation:

• Structure-based analyses: Secondary structure analysis using circular dichroism

• Size verification: Size exclusion chromatography or dynamic light scattering to confirm expected molecular weight and oligomeric state

• Immunofluorescence assays (IFA): To confirm antigenicity and cross-reactivity with anti-OsHV-1 antibodies

Expression Level Assessment:

• SDS-PAGE with densitometric analysis: To quantify expression levels

• ELISA: For quantitative determination of recombinant protein yield

A typical validation workflow should include at least three independent methods to conclusively verify the authenticity of the recombinant ORF84 protein before proceeding to functional studies.

What is known about the temporal expression pattern of ORF84 during viral infection?

ORF84 exhibits a distinct temporal expression pattern during OsHV-1 infection:

Expression Timeline:

• Early detection: The capsid-associated antigen encoded by ORF84 is first detected at 4 hours post-infection (hpi) using confocal microscopy and image analysis

• Expression increase: During the first 5 days post-infection, there is an 8-10 fold increase in capsid-associated protein expression

• Differential expression: ORF84 shows significantly higher expression increases compared to envelope glycoproteins, which show ≤2-fold increases during the same period

Cellular Localization Patterns:

• At early stages (4 hpi), similar levels of cytoplasmic and nuclear-associated protein are observed

• As infection progresses, distribution changes with increased nuclear localization corresponding to viral assembly

Quantitative Expression Data:

This expression pattern indicates that ORF84 is a key structural protein involved in capsid assembly during the viral replication cycle, making it a potential target for diagnostic development and therapeutic intervention.

How does the structural characterization of ORF84 contribute to understanding OsHV-1 capsid assembly?

Structural characterization of ORF84 provides critical insights into OsHV-1 capsid assembly and virus-host interactions:

Structural Approaches and Findings:

• Protein modeling: Homology modeling based on other herpesvirus capsid proteins suggests ORF84 contributes to the floor domain of hexons and pentons in the capsid structure

• Cryo-electron microscopy: Can reveal the spatial arrangement of ORF84 within the viral capsid and its interaction interfaces with other structural proteins

• X-ray crystallography: Of the recombinant protein can identify key structural motifs involved in protein-protein interactions during assembly

Functional Domains:
Analysis of the ORF84 sequence and structure reveals:

• N-terminal domains likely involved in capsid floor formation

• Central regions containing conserved structural elements shared with other herpesvirus capsid proteins

• C-terminal regions potentially involved in interactions with scaffolding proteins during assembly

Assembly Interactions:

• ORF84 likely interacts with other highly expressed structural proteins, including those encoded by viral genes with similar expression patterns

• The spatiotemporal coordination of ORF84 expression with other structural proteins (8-10 fold increase during first 5 days) suggests a regulated assembly process

Understanding these structural aspects is crucial for developing strategies to disrupt capsid assembly as a potential antiviral approach. The high conservation of capsid proteins among OsHV-1 variants makes ORF84 a particularly valuable target for broad-spectrum interventions.

What experimental approaches can be used to investigate ORF84 interactions with host immune factors?

Investigating interactions between ORF84 and host immune factors requires sophisticated experimental approaches:

Protein-Protein Interaction Studies:

• Yeast two-hybrid screening: To identify oyster proteins that interact with ORF84

• Co-immunoprecipitation: Using anti-ORF84 antibodies to pull down host interaction partners

• Proximity labeling: BioID or APEX2 fusions to ORF84 can identify proteins in close proximity within host cells

• Surface plasmon resonance (SPR): For measuring binding kinetics and affinity to purified host immune factors

Functional Immune Assays:

• In vitro hemocyte challenge: Exposing oyster hemocytes to recombinant ORF84 and measuring immune gene expression

• Neutralization assays: Testing if anti-ORF84 antibodies can neutralize viral infectivity

• Vaccine studies: Using recombinant ORF84 as a subunit vaccine candidate and measuring protection

Gene Expression Analysis:

Analysis of immune responses specifically to ORF84 represents a research gap, as current studies have examined whole virus challenges but not individual protein effects on host immunity. The differential regulation of immune factors like CgMyD88 variants during OsHV-1 infection suggests complex immune responses that might be partly driven by capsid proteins like ORF84 .

How can researchers develop an ORF84-based detection system for early diagnosis of OsHV-1 infection?

Developing an ORF84-based detection system requires leveraging the unique characteristics of this structural protein:

Molecular Detection Methods:

• Quantitative PCR: Designing primers/probes targeting ORF84 gene for sensitive viral DNA detection

• Droplet digital PCR: For absolute quantification with higher sensitivity than conventional qPCR

• LAMP (Loop-mediated isothermal amplification): For field-deployable rapid detection targeting ORF84

Protein-Based Detection Systems:

• ELISA development: Using recombinant ORF84 protein to generate specific antibodies for antigen detection

• Lateral flow assays: Development of field-deployable immunochromatographic tests

• Biosensor platforms: Surface-functionalized with anti-ORF84 antibodies for real-time detection

Performance Optimization:

Validation Strategy:

• Analytical validation using recombinant proteins and inactivated virus

• Testing with experimentally infected oysters at different time points to determine earliest detection window

• Field validation in areas with known OsHV-1 outbreaks

• Comparison with existing detection methods (conventional PCR, histopathology)

Early detection is crucial given that ORF84 expression is detectable from 4 hpi and increases significantly over 5 days , providing a viable window for early intervention before mortality occurs.

What strategies can be employed to analyze potential epitope regions within ORF84 for vaccine development?

Systematic epitope analysis of ORF84 provides foundation for rational vaccine design:

Computational Epitope Prediction:

• B-cell epitope prediction: Using algorithms that evaluate hydrophilicity, flexibility, accessibility, and antigenicity

• T-cell epitope prediction: MHC binding prediction tools adapted for mollusk systems

• Conservation analysis: Comparing sequences across different OsHV-1 variants to identify conserved epitope regions

• Structural prediction: Mapping predicted epitopes onto 3D structural models to confirm surface exposure

Experimental Epitope Mapping:

• Peptide array analysis: Overlapping peptides spanning the entire ORF84 sequence screened against sera from recovered oysters

• Phage display: For identifying immunodominant epitopes through biopanning with oyster antibodies

• Hydrogen-deuterium exchange mass spectrometry: To identify surface-exposed regions amenable to antibody recognition

• Truncation and mutation studies: To pinpoint essential antigenic regions

Immunogenicity Testing Framework:

Validation in Challenge Models:

• Immunization trials using different delivery methods and adjuvants

• Measurement of specific antibody responses

• Challenge with virulent OsHV-1 to assess protection

• Correlation of epitope-specific responses with survival outcomes

Given that previous exposure to OsHV-1 can result in immunity with 118 times lower risk of mortality than naive oysters , identifying the key protective epitopes within major structural proteins like ORF84 offers promise for vaccine development.

How can researchers investigate the potential role of ORF84 in viral transmission dynamics between infected and naïve oysters?

Investigating ORF84's role in viral transmission requires sophisticated experimental designs:

Transmission Study Models:

• Cohabitation experiments: Placing ORF84-immunized oysters with infected individuals to assess transmission blockade

• Water-borne transmission studies: Using filtered water from infected tanks to challenge naïve oysters with or without anti-ORF84 neutralizing antibodies

• Direct injection models: Comparing transmission efficiency of wild-type virus versus manipulated virus with altered ORF84

Molecular Tracking Approaches:

• Viral load quantification: Using ORF84-specific qPCR to track viral loads in donor and recipient oysters over time

• Expression analysis: Measuring ORF84 transcript levels at different stages of infection and relating to transmission efficiency

• Protein detection: Using immunohistochemistry to track ORF84 protein localization in tissues involved in viral shedding

Transmission Parameters Analysis:

Environmental Factors Assessment:

• Temperature effects on ORF84 expression and transmission (thermal shock experiments)

• Salinity impacts on capsid stability and transmission efficiency

• Water flow rates and their influence on transmission dynamics

This research is particularly important considering that adult C. gigas can carry OsHV-1 infection for lengthy periods, but reactivation of viral replication leading to mortality and transmission may require specific conditions . Understanding the role of structural proteins like ORF84 in maintaining viral integrity during transmission is crucial for developing intervention strategies.

What are the optimal conditions for expressing and purifying recombinant ORF84 protein to maintain structural integrity?

Optimizing expression and purification of recombinant ORF84 requires careful parameter tuning:

Expression Optimization:

• Vector selection: pET-based systems with T7 promoter for bacterial expression; pFastBac for baculovirus expression

• Host strain selection:

  • E. coli BL21(DE3) pLysS for reduced leaky expression

  • E. coli Rosetta for rare codon accommodation

  • Sf9 or Hi5 insect cells for eukaryotic folding environment

• Expression conditions:

  • Temperature: 16-18°C for slower expression to improve folding

  • Induction: 0.1-0.5 mM IPTG for bacterial systems

  • Media: TB or auto-induction media for higher yields

Purification Strategy Optimization:

Structural Integrity Assessment:

• Circular dichroism to confirm secondary structure content

• Thermal shift assays to assess stability under different buffer conditions

• Limited proteolysis to identify stable domains

• Negative-stain electron microscopy to check for proper folding and assembly

Storage Optimization:

• Stability testing at different temperatures (-80°C, -20°C, 4°C)

• Cryoprotectant screening (glycerol, sucrose, trehalose)

• Lyophilization trials with appropriate excipients

Based on research with other capsid proteins, adding molecular chaperones like GroEL/GroES to the expression system may significantly improve the yield of correctly folded ORF84 protein .

How can researchers design effective CRISPR/Cas9 approaches to study ORF84 function in the viral life cycle?

CRISPR/Cas9 approaches offer powerful tools for studying ORF84 function, though they require careful design for viral genome editing:

Target Site Selection:

• Conserved regions analysis: Identifying highly conserved regions within ORF84 across viral variants

• Critical domain targeting: Focusing on regions predicted to be essential for capsid assembly

• PAM site identification: Screening for optimal S. pyogenes Cas9 PAM sites (NGG) within ORF84

• Off-target prediction: Using computational tools to minimize off-target effects within viral and host genomes

Delivery System Optimization:

• Plasmid-based delivery: Co-transfection of Cas9 and sgRNA expression plasmids into virus-producing cells

• Ribonucleoprotein (RNP) complex: Direct delivery of pre-formed Cas9-sgRNA complexes

• Viral vectors: Using recombinant adenovirus or baculovirus for delivery into oyster cells

Experimental Approaches:

• In vitro genome editing:

  • Editing viral DNA extracted from virions before transfection

  • Screening for successful edits using T7 endonuclease assay or deep sequencing

• Cell culture editing:

  • Transfecting CRISPR components into permissive cell lines harboring viral genome

  • Analyzing viral replication after editing through qPCR and microscopy

Mutant Characterization Strategy:

Validation Approaches:

• Complementation studies with wild-type ORF84 expression

• Structural analysis of mutant virions using electron microscopy

• Host interaction studies using proteomics

• Trans-complementation systems for lethal mutations

This approach would advance understanding of specific roles of ORF84 in capsid assembly and stability during the viral life cycle, which is currently inferred primarily from expression patterns rather than direct functional evidence.

What bioinformatic approaches can be used to analyze ORF84 conservation and evolution across different OsHV-1 variants?

Comprehensive bioinformatic analysis of ORF84 evolution requires multi-faceted approaches:

Sequence Collection and Alignment:

• Database mining: Retrieving all available ORF84 sequences from GenBank, EMBL, and specialized virus databases

• Multiple sequence alignment: Using MAFFT or MUSCLE with parameters optimized for viral structural proteins

• Phylogenetic analysis: Maximum likelihood and Bayesian methods to reconstruct evolutionary relationships

• Recombination detection: Using RDP4 or similar tools to identify potential recombination events

Evolutionary Rate Analysis:

• BEAST analysis: Bayesian evolutionary analysis to estimate the molecular clock rate of ORF84

• Selection pressure analysis: Using PAML, FUBAR, or MEME to identify sites under positive or negative selection

• Codon usage analysis: Comparing ORF84 codon usage with host genes to detect adaptation

Structural Conservation Mapping:

Comparative Genomics:

• Synteny analysis: Examining the genomic context of ORF84 across related viruses

• Gene content analysis: Comparing presence/absence patterns of ORF84 orthologues

• Variant calling pipeline: Identifying SNPs and InDels across viral genomes and assessing their impact

The evolutionary rate of OsHV-1 has been estimated at approximately 6.787E-05 nucleotide substitutions per site per year , which is higher than expected for a DNA virus. Using this information, researchers can estimate the timeline of ORF84 divergence across different viral strains and host species, providing insights into host adaptation and potential for cross-species transmission.

How can researchers develop an in vitro system to study ORF84 assembly into capsid-like structures?

Developing an in vitro capsid assembly system for ORF84 requires systematic methodological approaches:

Protein Component Preparation:

• Expression of multiple capsid proteins: ORF84 along with other putative capsid proteins identified as highly expressed

• Optimization of protein ratios: Based on stoichiometry determined from purified virions

• Buffer screening: Systematic testing of pH, ionic strength, and additives to promote assembly

• Redox conditions: Optimization of oxidizing/reducing environment for proper disulfide bond formation

Assembly Reaction Design:

• Concentration-dependent assembly: Titration of protein concentrations to determine critical assembly threshold

• Temperature and time course: Finding optimal conditions for ordered assembly

• Nucleic acid requirement: Testing if scaffold DNA/RNA is needed for proper assembly

• Stepwise versus co-expression assembly: Comparing sequential addition versus simultaneous mixing

Analytical Techniques for Assembly Monitoring:

Assembly Validation Approaches:

• Structural comparison with native virions using electron microscopy

• Antibody recognition using the same antibodies that detect native capsids

• Stability assays under various conditions (pH, temperature, salt)

• DNA packaging assays to test functionality

This in vitro system would provide crucial insights into the assembly pathway of OsHV-1 capsids and the specific role of ORF84, which could identify critical steps for targeted intervention. The system could also be used to screen for small molecules that disrupt assembly as potential antiviral compounds.

What methodological approaches can be used to study the interaction between ORF84 and other viral structural proteins?

Investigating interactions between ORF84 and other viral structural proteins requires multi-technique approaches:

Protein-Protein Interaction Screening:

• Yeast two-hybrid (Y2H) screening: Systematic testing of ORF84 against other viral ORFs

• Mammalian two-hybrid assays: For verification in more native-like cellular environments

• Split-reporter assays: Using BiFC, BRET, or FRET to visualize interactions in living cells

• Protein complementation assays: For validation of specific interaction pairs

Structural Characterization of Complexes:

• Crosslinking mass spectrometry (XL-MS): To identify interaction interfaces

• Hydrogen-deuterium exchange MS: For mapping binding regions through solvent accessibility changes

• Single-particle cryo-EM: For structural determination of multi-protein complexes

• X-ray crystallography: For high-resolution studies of co-crystallized protein domains

Quantitative Binding Analysis:

Functional Validation in Viral Context:

• Co-immunoprecipitation from infected cells at different time points

• Immunofluorescence co-localization studies during infection progression

• Proximity labeling approaches (BioID, APEX) in infected cells

• Mutational analysis of interface residues identified from structural studies

The expression analysis of OsHV-1 ORFs has revealed several highly expressed putative capsid proteins alongside ORF84 , making them primary candidates for interaction studies. Understanding these interactions could reveal assembly pathways and potential vulnerabilities in the viral structure.